Donor-derived regulatory T cell injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Donor-derived regulatory T cell injection, covering 2025-09-30 to 2025-09-30. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of Refractory cGVHD by Donor-derived Treg Cell Injection Combined With Recombinant Human Interleukin-2 [EARLY_Phase 1]